Halia Therapeutics
Lehi
About Halia Therapeutics
Halia Therapeutics is a preclinical-stage biopharmaceutical company manufacturing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. Halia Therapeutics does this by advancing innovative medicines that target the immune system's response to resolve chronic inflammation and eliminate the damage caused by aberrantly activated immune responses. Halia Therapeutics takes a novel approach to drug discovery by translating advances in understanding of the role of inflammation in human pathologies such as cancer and neurodegenerative diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $47.6M
- Last round: Series Unknown (Jul 2025)
- Website: haliatx.com
- Phone: 801-753-5707
Industries & Categories
Biotechnology, Medical, Neuroscience, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/halia-therapeutics-104400 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.